Browsing Tag
icosapent ethyl
3 posts
AHA 2025: New REDUCE-IT results reveal Vascepa lowers heart attack and stroke risk even when LDL-C is optimal
Find out how AHA 2025 REDUCE-IT results show Vascepa reduces heart attack and stroke risk even when LDL-C is optimal — reshaping cardiovascular prevention.
Strides Pharma subsidiary gets FDA approval for Icosapent Ethyl Capsules
In a significant pharmaceutical breakthrough, Strides Pharma Science Limited announces that its wholly owned subsidiary, Strides Pharma Global…
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA)…